In Reply Dr Finucane’s Letter highlights the potential underestimation of adherence bias in our study. We acknowledge that on-treatment analysis is not protected against selection bias. There is a vast literature about the implications of treatment adherence on health outcomes. Our knowledge and understanding of medication adherence cannot be extrapolated to the assessment of device adherence that requires hours of use to be effective.